We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

PD-L1: A Therapeutic Target for Malignant Melanomas in Dogs

News   Apr 23, 2021 | Original story from Hokkaido University

 
PD-L1: A Therapeutic Target for Malignant Melanomas in Dogs

Antitumor effect of anti-PD-L1 antibody. CT images of oral malignant melanoma (upper left) and its lung metastases (lower left) observed in a Pomeranian (12 years old, male). As a result of treatment with anti-PD-L1 antibody, all detectable tumors disappeared (right panels). Credit: Naoya Maekawa, et al

 
 
Advertisement
 

RELATED ARTICLES

Delaying Second COVID-19 Vaccine Dose May Prevent Deaths, Under Certain Conditions

News

A study has found that delaying the second dose of covid-19 vaccines, at least for people aged under 65, could result in up to 20% lower mortality, but only under certain conditions.

READ MORE

Skin-Patch Vaccine for Dengue Fever Successful in Preclinical Models

News

A dengue virus vaccine candidate has shown promising results in animal models, producing a protective immune response in dengue-infected mice.

READ MORE

How Tumors Alter Whole-Body Metabolism at the Molecular Level

News

A new study with zebrafish shows that melanomas alter the metabolism of healthy tissues elsewhere in the body.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE